NOTA:FRA
Novartis AG
143,00 €
arrow_downward
-0,69%(-1,00) 1D
13 nën, 10:00:00 m.d., GMT+1 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për NOTA...
Hap
144,00 €
I lartë
144,00 €
I ulët
143,00 €
Kapitalizimi i tregut
327,55 mld
Vëllimi mesatar
8,00
Vëllimi
0,00
Maksimumi 52-javor
146,00 €
Minimumi 52-javor
105,50 €
Numri i punonjësve
75 mijë
Hap
144,00 €
I lartë
144,00 €
I ulët
143,00 €
Kapitalizimi i tregut
327,55 mld
Vëllimi mesatar
8,00
Vëllimi
0,00
Maksimumi 52-javor
146,00 €
Minimumi 52-javor
105,50 €
Numri i punonjësve
75 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Yahoo Finance
·
1 ditë më parë
New long-term Rhapsido® (remibrutinib) Phase III data show sustained efficacy through week 52 in chronic inducible urticaria (CIndU)
Investor's Business Daily
·
2 ditë më parë
How Amgen, In A Buy Zone, Is Taking On Novartis With A First-Ever
Investor's Business Daily
·
3 ditë më parë
How Stock Of The Day TG Therapeutics Is Making Waves For Its Rivals
Investing.com
·
6 ditë më parë
Novartis shelves potential blockbuster pelacarsen as landmark study fails
Profili
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Rreth Novartis AG
Drejtori ekzekutivVasant Narasimhan
Punonjësit75,3 mijë
Themeluar më7 mar 1996
SeliaBasel, Basel City, Zvicër
SektoriHealth Care
Industria-
Uebsajtinovartis.com